BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13492453)

  • 1. [Use of staphylococcal anatoxin in therapy of suppurative surgical diseases of the skin and subcutaneous tissue].
    ZEBRIN AG
    Khirurgiia (Mosk); 1957 Sep; 33(9):106-12. PubMed ID: 13492453
    [No Abstract]   [Full Text] [Related]  

  • 2. [Result of the treatment of suppurative skin diseases with staphylococcal anatoxin A2].
    SHEKLAKOV ND
    Vestn Venerol Dermatol; 1953; 5():15-7. PubMed ID: 13136814
    [No Abstract]   [Full Text] [Related]  

  • 3. [Allergy to staphylococcal anatoxin. III. Skin test for staphylococcal anatoxin following anatoxin therapy].
    WAGNER V; MALY V
    Cas Lek Cesk; 1952 May; 91(22):646-9. PubMed ID: 14390245
    [No Abstract]   [Full Text] [Related]  

  • 4. [Utilization of staphylococcal anatoxin in dermatology].
    HORACEK J
    Bratisl Lek Listy; 1953; 33(9):829-35. PubMed ID: 13140805
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience in the use of staphylococcal anatoxin in suppurative surgery in children].
    Kaplan VM
    Vestn Khir Im I I Grek; 1968 Apr; 100(4):101-5. PubMed ID: 5671804
    [No Abstract]   [Full Text] [Related]  

  • 6. [Staphylococcal anatoxin in the complex therapy of children with suppurative-septic diseases of the skin and subcutaneous cellular tissue].
    Kaplan VM
    Khirurgiia (Mosk); 1965 Jul; 41(7):33-6. PubMed ID: 5878619
    [No Abstract]   [Full Text] [Related]  

  • 7. [Data on the staphylococcal anatoxin therapy of patients with coccogenous eczema].
    KOROSSY S; DOBIAS G; BACKHAUSZ R; GOZONY M
    Orv Hetil; 1959 Jan; 100(4):134-9. PubMed ID: 13633294
    [No Abstract]   [Full Text] [Related]  

  • 8. Local effect of staphylococcal toxin; studies on blood vessels with particular reference to phenomenon dermonecrosis.
    THAL A; EGNER W
    AMA Arch Pathol; 1954 May; 57(5):392-404. PubMed ID: 13147651
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of staphylococcal anatoxin A2 in the treatment of pyoderma in miners].
    ZATOLOKIN FD
    Sov Med; 1959 Apr; 23(4):130-1. PubMed ID: 13659205
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyogenic skin infections; preliminary report, an outline of some medical and nursing care technics after a control program of eighteen months.
    GOLDMAN L
    Med Times; 1959 Jan; 87(1):56-8. PubMed ID: 13621893
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isolation and bacteriological characteristics of Micrococcus pyogenes present in the air, in personnel and in patients of the dermatological wards of the Chief Hospital S. Anna di Ferrara].
    FERRUCCI M; MOLINARI R
    Arcisp S Anna Ferrara; 1958; 11(1):99-110. PubMed ID: 13510081
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with the thrombocytopenia index of Storck and Hoigné produced by Micrococcus pyogenes anatoxin in coccogenous eczema].
    KOROSSY S; GOZONY M
    Orv Hetil; 1957 Jul; 98(28):761-3. PubMed ID: 13465137
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the electrophoretic pattern of the blood serum of patients of staphylococcic pyodermitis after anatoxin therapy].
    MOLINARI R; FERRUCCI M
    Arcisp S Anna Ferrara; 1957; 10(6):1559-63. PubMed ID: 13510072
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preparation of staphylococcal toxin and anatoxin in cultures on cellophane].
    JOHANOVSKY J
    Cesk Epidemiol Mikrobiol Imunol; 1956 Mar; 5(1):41-6. PubMed ID: 13364973
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiements and therapeutic studies with Micrococcus pyogenes anatoxin. II. Therapeutic results].
    CSOKA E; BIRO L
    Borgyogy Venerol Sz; 1956 Mar; 10(2):73-7. PubMed ID: 13315533
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathogenic power of staphylococci in various cutaneous lesions].
    PECORA G
    Athena; 1954; 20(8-9):315-6. PubMed ID: 13208465
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental and therapeutic results with a Staphylococcus anatoxin].
    BIRO L; CSOKONAY L; NEUWIRTH M; CSOKA I
    Borgyogy Venerol Sz; 1956 Jan; 10(1):6-12; contd. PubMed ID: 13304140
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison between the specific immunity obtained with plain staphylococcic anatoxin and with anatoxin treated with phosphorylated hesperidin].
    RICHOU R; RICHOU H
    C R Hebd Seances Acad Sci; 1959 Jan; 248(2):321-3. PubMed ID: 13619169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chloromycetin in the treatment of suppurative skin diseases].
    TEMPSKI J; CHYLEWSKI W
    Przegl Dermatol; 1956; 6(6):575-84. PubMed ID: 13408365
    [No Abstract]   [Full Text] [Related]  

  • 20. [Staphylococcic skin infections and their treatment with dynamycin].
    FORTIER D; COSSETTE Y; JACOB D
    Laval Med; 1955 Oct; 20(8):1065-83. PubMed ID: 13279219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.